Vaxart News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.50 -7.91% 5.82 19:58:19
Open Price Low Price High Price Close Price Prev Close
6.05 5.51 6.0964 5.77 6.32
more quote information »

Recent News

Date Time Source Heading
12/01/202116:06EDGARStatement of Changes in Beneficial Ownership (4)
12/01/202108:21SEEKVaxart acquires second GMP manufacturing facility
12/01/202108:00GLOBEVaxart Announces Acquisition of Second GMP Manufacturing..
11/23/202108:00GLOBEVaxart to Present at World Vaccine & Immunotherapy Congress..
11/18/202116:22SEEKVaxart oral flu vaccine offers greater protection in human..
11/18/202116:02GLOBEStanford Scientists First To Identify New Cellular..
11/17/202113:29SEEKComplete data from Vaxart oral COVID-19 vaccine study in..
11/16/202108:00GLOBEVaxart Announces Publication of Complete Data from..
11/11/202116:01GLOBEVaxart to Participate at Upcoming Conferences
11/04/202117:22SEEKVaxart EPS in-line, beats on revenue
11/04/202116:08EDGARCurrent Report Filing (8-k)
11/04/202116:01GLOBEVaxart Provides Business Update and Reports Third Quarter..
11/03/202116:01SEEKVaxart draws bullish rating from Cantor on prospects for..
10/26/202108:00PRNUSVaxart Doses First Subject in Phase II COVID-19 Oral Tablet..
10/13/202118:54TRMNIs Vaxart Stock a Buy Right Now? This Is What You Need to..
10/13/202117:58EDGARStatement of Changes in Beneficial Ownership (4)
10/08/202108:13SEEKMIC, FBIO and CEI among pre market gainers
10/08/202106:51TRMNVaxart’s Oral COVID-19 Vaccine Reflects Optimism; Shares..
10/07/202117:20EDGARInitial Statement of Beneficial Ownership (3)
10/07/202116:13PRNUSNew Duke University-led Study Shows That Vaxart's Oral..
10/06/202108:00PRNUSVaxart Begins Recruiting in Global Phase II COVID-19 Oral..
9/27/202108:00PRNUSVaxart Appoints Dr. James F. Cummings as Chief Medical..
9/22/202116:05PRNUSVaxart To Present at Upcoming Vaccine Conferences
9/21/202116:19EDGARCurrent Report Filing (8-k)
9/21/202116:15PRNUSVaxart Announces Creation of Manufacturing and..
9/20/202108:00PRNUSVaxart to Present at the 2021 Cantor Virtual Global..
9/16/202114:43EDGARAmended Current Report Filing (8-k/a)
9/16/202106:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/16/202106:05EDGARCurrent Report Filing (8-k)
9/16/202106:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/13/202119:30EDGARStatement of Changes in Beneficial Ownership (4)
9/07/202116:20PRNUSVaxart to Present at the H.C. Wainwright 23rd Annual Global..
8/23/202118:33EDGARStatement of Changes in Beneficial Ownership (4)
8/23/202118:32EDGARInitial Statement of Beneficial Ownership (3)
8/23/202116:23EDGARCurrent Report Filing (8-k)
8/23/202109:00PRNUSVaxart Announces Highly Regarded Biotech Executive Julie M...
8/19/202116:02PRNUSVaxart Announces Creation of New Scientific and Clinical..
8/15/202107:06TRMNVaxart’s Pills seem Prudent, but Caution Remains Key
8/11/202118:54EDGARStatement of Changes in Beneficial Ownership (4)
8/11/202118:53EDGARStatement of Changes in Beneficial Ownership (4)
8/05/202117:04SEEKVaxart EPS beats by $0.01, beats on revenue
8/05/202116:25EDGARQuarterly Report (10-q)
8/05/202116:10EDGARCurrent Report Filing (8-k)
8/05/202116:02PRNUSVaxart Provides Business Update and Reports Second Quarter..
8/03/202107:37TRMNFDA Approves IND for Vaxart’s Oral Tablet; Shares Rise
8/02/202116:12EDGARCurrent Report Filing (8-k)
8/02/202108:44SEEKVaxart stock jumps 12% after FDA clears IND for oral..
8/02/202108:00PRNUSFDA Clears Vaxart's IND Application for S-Only Oral Tablet..
7/29/202109:07SEEKVaxart shows booster effect of vaccine platform with..
7/29/202108:22PRNUSVaxart Reports Boosting Immune Responses in Subjects..
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.